108 related articles for article (PubMed ID: 31997687)
1. Retrospective study of men with
Jansåker F; Boel JB; Frimodt-Møller N; Knudsen JD
Scand J Prim Health Care; 2020 Mar; 38(1):101-103. PubMed ID: 31997687
[No Abstract] [Full Text] [Related]
2. In-vitro sensitivity of organisms causing urinary tract infections to four common oral antibiotics and to pivmecillinam.
Bansal AS
West Indian Med J; 1988 Dec; 37(4):201-4. PubMed ID: 3266047
[No Abstract] [Full Text] [Related]
3. Epidemiological factors associated with ESBL- and non ESBL-producing E. coli causing urinary tract infection in general practice.
Hertz FB; Schønning K; Rasmussen SC; Littauer P; Knudsen JD; Løbner-Olesen A; Frimodt-Møller N
Infect Dis (Lond); 2016; 48(3):241-5. PubMed ID: 26523346
[TBL] [Abstract][Full Text] [Related]
4. Treatment duration of pivmecillinam in men, non-pregnant and pregnant women for community-acquired urinary tract infections caused by Escherichia coli: a retrospective Danish cohort study.
Boel JB; Jansåker F; Hertz FB; Hansen KH; Thønnings S; Frimodt-Møller N; Knudsen JD
J Antimicrob Chemother; 2019 Sep; 74(9):2767-2773. PubMed ID: 31098630
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic switch after treatment with UTI antibiotics in male patients.
Skow MAH; Vik I; Høye S
Infect Dis (Lond); 2020 Jun; 52(6):405-412. PubMed ID: 32174201
[No Abstract] [Full Text] [Related]
6. Retrospective evaluation of nitrofurantoin and pivmecillinam for the treatment of lower urinary tract infections in men.
Montelin H; Forsman KJ; Tängdén T
PLoS One; 2019; 14(1):e0211098. PubMed ID: 30682092
[TBL] [Abstract][Full Text] [Related]
7. Prescription of antibiotics for urinary tract infection in general practice in Denmark.
Holm A; Cordoba G; Aabenhus R
Scand J Prim Health Care; 2019 Mar; 37(1):83-89. PubMed ID: 30689491
[TBL] [Abstract][Full Text] [Related]
8. Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli.
Mulder M; Verbon A; Lous J; Goessens W; Stricker BH
Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2283-2290. PubMed ID: 31494829
[TBL] [Abstract][Full Text] [Related]
9. Exploring the relationship between primary care antibiotic prescribing for urinary tract infections, Escherichia coli bacteraemia incidence and antimicrobial resistance: an ecological study.
Lishman H; Costelloe C; Hopkins S; Johnson AP; Hope R; Guy R; Muller-Pebody B; Holmes A; Aylin P
Int J Antimicrob Agents; 2018 Dec; 52(6):790-798. PubMed ID: 30145249
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of pivmecillinam for treatment of lower urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
Titelman E; Iversen A; Kalin M; Giske CG
Microb Drug Resist; 2012 Apr; 18(2):189-92. PubMed ID: 22204597
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for resistance and MDR in community urine isolates: population-level analysis using the NHS Scotland Infection Intelligence Platform.
Malcolm W; Fletcher E; Kavanagh K; Deshpande A; Wiuff C; Marwick C; Bennie M
J Antimicrob Chemother; 2018 Jan; 73(1):223-230. PubMed ID: 29040608
[TBL] [Abstract][Full Text] [Related]
12. Balancing treatment with resistance in UTIs.
The Lancet
Lancet; 2018 May; 391(10134):1966. PubMed ID: 29864008
[No Abstract] [Full Text] [Related]
13. [Prescriptions of a new antibiotic following treatment with sulfamethizole or pivmecillinam].
Bjerrum L; Dessau RB; Hallas J
Ugeskr Laeger; 2003 Sep; 165(39):3732-5. PubMed ID: 14558387
[No Abstract] [Full Text] [Related]
14. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections.
Jansåker F; Frimodt-Møller N; Sjögren I; Dahl Knudsen J
J Antimicrob Chemother; 2014 Mar; 69(3):769-72. PubMed ID: 24107388
[TBL] [Abstract][Full Text] [Related]
15. [Update on current care guidelines: urinary tract infections].
Wuorela M; Kouri T; Laato M; Lipponen P; Sammalkorpi K; Uhari M; Uusitalo L; Vuento R
Duodecim; 2011; 127(21):2334-5. PubMed ID: 22204148
[TBL] [Abstract][Full Text] [Related]
16. Comparison of long-term, low-dose pivmecillinam and nitrofurantoin in the control of recurrent urinary tract infection in children. An open, randomized, cross-over study.
Carlsen NL; Hesselbjerg U; Glenting P
J Antimicrob Chemother; 1985 Oct; 16(4):509-17. PubMed ID: 4066562
[TBL] [Abstract][Full Text] [Related]
17. Pivmecillinam--therapy of choice for lower urinary tract infection.
Graninger W
Int J Antimicrob Agents; 2003 Oct; 22 Suppl 2():73-8. PubMed ID: 14527775
[TBL] [Abstract][Full Text] [Related]
18. Different antibiotic regimes in men diagnosed with lower urinary tract infection - a retrospective register-based study.
Kornfält Isberg H; Hedin K; Melander E; Mölstad S; Cronberg O; Engström S; Lindbäck H; Neumark T; Ekman GS; Beckman A
Scand J Prim Health Care; 2020 Sep; 38(3):291-299. PubMed ID: 32686974
[TBL] [Abstract][Full Text] [Related]
19. The influence of long-term treatment with mecillinam on fecal Escherichia coli.
Møller JK; Stenderup A
Scand J Infect Dis; 1984; 16(2):223-4. PubMed ID: 6330882
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model.
Vellinga A; Tansey S; Hanahoe B; Bennett K; Murphy AW; Cormican M
J Antimicrob Chemother; 2012 Oct; 67(10):2523-30. PubMed ID: 22729920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
